Skip to main content
CDC Website

Health Care Planning

Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)

This initiative will support multilevel and multidisciplinary intervention research to improve quality of life and promote successful aging among people with HIV with HIV associated non-AIDS comorbidities across the life course from racial and ethnic and lower socioeconomic status groups.

Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)

The Population Assessment of Tobacco and Health (PATH) Study provides the scientific community with biospecimens (urine, plasma, serum, and genomic DNA) and related research data on behaviors, attitudes, biomarkers and health outcomes associated with tobacco use in the U.S. This opportunity allows investigators to apply for access to the biospecimens from the PATH Study.

Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)

The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strategy for next-generation treatments for HIV and HIV-associated comorbidities, coinfections and complication and preventive strategies for HIV, as well as facilitating the translation of research findings into drug products that enables submission of an Investigational New Drug (IND) application to the FDA.

Notice of Special Interest (NOSI): Advancing Biomedical Research in Pulmonary Non-Tuberculosis Mycobacterial (NTM) Infections

This NOSI aims to stimulate advances in diagnosis and treatment of NTM infections that cause or exacerbate pulmonary disease such as Mycobacterium abscessus, Mycobacterium avium complex, and Mycobacterium kansasii.  Areas of interest include but are not limited to:

Expanding Access to Hepatitis C Prevention, Testing, and Treatment in Prisons

This packet of recommendations discusses how in October 2022, INHSU Prisons and the Coalition for Global Hepatitis Elimination (CGHE), Task Force for Global Health convened a workshop on the strategies for expanding access to hepatitis C virus (HCV) prevention, testing, and treatment in prison settings. During the workshop, barriers and recommendations to accelerating HCV elimination in prison settings were examined in four areas: 1) Policy, 2) Implementation, 3) Financing, and 4) Awareness.

TelePrEP Online Learning Series

This TelePrEP Online Learning Series provides information and resources to health departments, community-based organizations, and community health centers wanting to expand, strengthen, or develop a telePrEP program. 

Innovation Health Practices

The United States Agency for International Development (USAID) is issuing this Broad Agency Announcement (BAA) to seek participants to co-create, co-design, co-invest, and collaborate on creating, piloting, and scaling innovative research and development interventions utilizing innovative health practices to help reduce disease and mortality rates worldwide.

BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research

The USAMRDC’s mission is to provide solutions to medical problems of importance to the American Service Member at home and abroad, as well as to the general public at large. The scope of this effort and the priorities attached to specific projects are influenced by changes in military and civilian medical science and technology (S&T), operational requirements, military threat assessments, and national defense strategies. Extramural research and development programs play a vital role in the fulfillment of the objectives established by the USAMRDC.

National HIV/AIDS Strategy for the United States: Updated to 2020

This report is an updated Strategy that looks ahead to 2020 and spells out the U.S. goals and objectives for the prevention and elimination of HIV infection. The Strategy has four main goals: 1) reducing new HIV infections; 2) increasing access to care and improving health health outcomes for people living with HIV; 3) reducing HIV-related health disparities and health inequities; and 4) achieving a more coordinated national response to the HIV epidemic.